From After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease:

Equillium Dan Bradbury

Equillium Dan Bradbury—

Equillium CEO and co-founder Dan Bradbury, photo courtesy of Equillium

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Xconomy Insight · Special Report
Biotech Startups: How to Succeed in a COVID-19 World
Industry experts explain what it takes to launch a new biotech company

From Our Editors · Special Report
Xcelerating Life Sciences Philadelphia: Special Report
Becoming the Cell & Gene Therapy Hub

Xconomy on Demand

We offer a number of ways to subscribe for free!